Macfarlane Group On Track for 2025 Forecasts Despite Pitreavie Setback

• Recovery is already underway, not just planned.
• There is a clear timeline to normal operations – the end of March 2026.
• The capex is not merely repair; management says it will “create capacity for growth”.

My take: £1.2m is a modest investment for a group of Macfarlane’s scale, which helps explain why full year expectations remain intact. The more interesting line is “capacity for growth” – a hint that the site may come back stronger, not just back to baseline. Execution and customer retention will be the proof points over the next two quarters.

Pension scheme: de-risking via a potential buy-in

The Group is positioning its pension scheme for a possible “buy-in”. A buy-in is when an insurer is paid to take on the pension liabilities for a scheme, reducing future risk for the company. These transactions can be complex and usually follow a period of work to tidy up data, benefits, and funding positions.

As part of that process, Macfarlane will recognise a non-recurring accounting charge of £2m-£3m. The company says this reflects an increase in the expected cost of historic equalisation of pensions (equalisation typically refers to aligning benefits where past rules created differences, such as GMP equalisation).

Why it matters:

• The charge affects reported profit, but it is described as non-recurring and linked to the accounting treatment around equalisation, not ongoing trading.
• The strategic goal is to “reduce future risk and minimise any further requirement for cash contributions”. That is a positive direction for medium-term cash flow certainty if the buy-in proceeds on acceptable terms.
• The exact timing and terms of any buy-in are not disclosed.

Overall, I view this as sensible housekeeping. Many UK corporates are taking advantage of improved scheme funding and insurer capacity to lock down pension risk. The near-term accounting pain can be worth the long-term reduction in volatility and cash calls.

Distribution and Manufacturing: priorities, not detail

Macfarlane runs two divisions – Packaging Distribution and Manufacturing Operations. Today’s statement emphasises management focus on “stabilising the Pitreavie business and implementing actions to improve the performance of the Distribution business.” There are no divisional growth rates, margins, or order trends in this update – not disclosed.

Read between the lines and you get a clear near-term agenda: keep Pitreavie on its recovery track and sharpen Distribution performance. Given Distribution is the larger engine in the group’s model, operational tweaks here can have an outsized impact even without revenue fireworks.

What’s positive, what’s not

Positives I see

• FY 2025 performance guided in line with market expectations despite disruption – a mark of resilience.
• Clear, costed plan for Pitreavie with a defined end-Q1 2026 milestone.
• Pension de-risking signals discipline and potential for steadier future cash requirements.

Watch-outs

• The £2m-£3m accounting charge will drag on reported profit, even if it is non-recurring.
• Operational recovery has to be delivered on time – any slippage beyond Q1 2026 would likely test investor patience.
• There is no fresh read on trading momentum by division – we’ll need the next update for detail.

Company footprint: scale that supports resilience

Macfarlane has been listed since 1973 and operates across 43 sites with over 1,000 employees, mainly in the UK, plus Ireland, Germany, and the Netherlands. It serves more than 20,000 customers, working with 1,700 suppliers and distributing and manufacturing 600,000+ product lines across sectors from e-commerce and logistics to medical, automotive, and aerospace.

That breadth helps cushion site-specific issues and supports the “in line” guidance today. It also gives the group room to redirect capacity and support customers while Pitreavie gets back to full strength.

What I’m watching next

• Pitreavie recovery milestones – visible progress towards full operational capability by the end of Q1 2026.
• Any confirmation of a pension buy-in – timing, insurer partner, and whether it materially reduces future cash contributions.
• Distribution performance actions – evidence of efficiency gains or service improvements feeding through to margins in 2026.
• Full year results – whether Adjusted Operating Profit lands at the £19.1m consensus and how one-offs are presented.

Bottom line: steady hands, sensible de-risking

This is a pragmatic, operations-first update. Macfarlane’s guidance holds steady, the Pitreavie plan is funded and timed, and the pension move should lower future volatility even if it creates a one-off accounting charge now. There is nothing flashy here – and that’s exactly the point. For a packaging group built on service, availability, and efficiency, dependable execution is the investment case.

If management hits the Q1 2026 target at Pitreavie and follows through on pension de-risking, 2026 could start with a cleaner base and a bit more growth capacity. For now, “in line” is the right place to be.